ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

MBIO Mustang Bio Inc

0.187
-0.0244 (-11.54%)
May 31 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 6,256,552
Bid Price 0.1852
Ask Price 0.1882
News (1)
Day High 0.2198

Low
0.16

52 Week Range

High
8.17

Day Low 0.185
Share Name Share Symbol Market Stock Type
Mustang Bio Inc MBIO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0244 -11.54% 0.187 18:59:45
Open Price Low Price High Price Close Price Previous Close
0.218 0.185 0.2198 0.2012 0.2114
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
5,841 6,256,552 US$ 0.2091523 US$ 1,308,572 - 0.16 - 8.17
Last Trade Type Quantity Price Currency
18:59:47 20 US$ 0.1881 USD

Mustang Bio Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.08M 10.39M - 0 -51.6M -4.97 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Mustang Bio News

Date Time Source News Article
5/31/202416:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of..
5/21/202415:15Edgar (US Regulatory)Form 8-K - Current report
5/13/202405:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]
5/02/202415:01GlobeNewswire Inc.Mustang Bio Announces Closing of $4 Million Public Offering
4/29/202419:00GlobeNewswire Inc.Mustang Bio Announces Pricing of $4 Million Public Offering
3/28/202408:00GlobeNewswire Inc.Mustang Bio Announces Vision for CAR T-Cell Therapy Platform..
3/11/202415:30Edgar (US Regulatory)Form 8-K - Current report
3/11/202415:05GlobeNewswire Inc.Mustang Bio Reports Full-Year 2023 Financial Results and..
3/11/202415:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/07/202406:30GlobeNewswire Inc.Mustang Bio Announces Publication in Nature Medicine of Data..
2/14/202415:15Edgar (US Regulatory)Form 8-K - Current report
1/25/202415:07Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No MBIO Message Board. Create One! See More Posts on MBIO Message Board See More Message Board Posts

Historical MBIO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.20850.2990.160.225700624,755,704-0.0215-10.31%
1 Month0.27790.43880.160.23282818,547,261-0.0909-32.71%
3 Months1.351.370.160.25641662,973,370-1.16-86.15%
6 Months1.421.660.160.3032641,439,912-1.23-86.83%
1 Year6.328.170.160.422882746,208-6.13-97.04%
3 Years50.8560.900.1617.63793,501-50.66-99.63%
5 Years49.6589.700.1635.61958,049-49.46-99.62%

Mustang Bio Description

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies and CAR T therapies for solid tumors.